NovaBridge Biosciences Operating Lease Liability
NovaBridge Biosciences (NBP) had Operating Lease Liability of $3.07 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-04-07
- 2023-12-31: Operating Lease, Liability 44.99M CNY.
- 2022-12-31: Operating Lease, Liability 56.03M CNY.
- 2021-12-31: Operating Lease, Liability 112.45M CNY.
- 2020-12-31: Operating Lease, Liability 13.60M CNY.
CNY
| Period end | Operating Lease, Liability |
|---|---|
| 2023-12-31 | 44.99M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 56.03M CNY 20-F · filed 2023-05-01 |
| 2021-12-31 | 112.45M CNY 20-F · filed 2022-04-29 |
| 2020-12-31 | 13.60M CNY 20-F · filed 2021-04-28 |
| 2019-12-31 | 14.30M CNY 20-F · filed 2020-04-29 |
| 2019-01-01 | 11.33M CNY 20-F · filed 2022-04-29 |
USD
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $3.07M 20-F · filed 2026-04-07 |
| 2025-09-30 | $3.27M 6-K · filed 2025-12-18 |
| 2025-06-30 | $3.48M 6-K · filed 2025-10-06 |
| 2024-12-31 | $3.88M 20-F · filed 2025-04-03 |
| 2023-12-31 | $6.34M 20-F · filed 2024-04-30 |
| 2022-12-31 | $8.12M 20-F · filed 2023-05-01 |
| 2021-12-31 | $17.65M 20-F · filed 2022-04-29 |
| 2020-12-31 | $2.08M 20-F · filed 2021-04-28 |
| 2019-12-31 | $2.05M 20-F · filed 2020-04-29 |